A recent preprint study from NOVOS presents promising findings on a multi-target nutritional supplement designed to improve vascular health in adults aged 40 and over. Conducted at the University of Surrey and led by Professor Christian Heiss, this randomized, double-blind, placebo-controlled trial involved 61 healthy participants, with 43 completing the six-month intervention. The results indicate significant improvements in endothelial function, arterial stiffness, and systolic blood pressure, suggesting a coherent shift in vascular aging biology.

These findings are particularly relevant as they mark a departure from the often vague claims associated with nutritional supplements, providing measurable outcomes across established cardiovascular markers. The study’s design reflects a growing trend in the longevity sector toward clinical rigor, emphasizing the importance of replicable and peer-reviewed data in the field of preventive health.

The key takeaway is that this research underscores the potential of multi-component interventions to influence cardiovascular aging, signaling a shift toward more scientifically grounded approaches in the supplement industry. As the field evolves, the challenge remains to validate these early findings through larger, long-term studies that can demonstrate sustained effects on healthspan and longevity.

Source: longevity.technology